Asia Pacific Pharmaceutical (002370.SZ) released its first quarter financial results, with a net loss attributable to shareholders of 7.8032 million yuan, an increase of 160.25% compared to the previous year.

Wisdom Financial APP News, Asia Pacific Pharmaceutical (002370.SZ) released its first quarter report for 2025. The company's operating income was 64.55 million yuan, a decrease of 42.73% year-on-year. Net loss attributable to shareholders of the listed company was 7.8032 million yuan, an increase of 160.25% year-on-year. Net loss attributable to shareholders of the listed company excluding non-recurring gains and losses was 7.5638 million yuan, an increase of 242.05% year-on-year. Basic earnings per share was 0.0105 yuan.